Intravenous lacosamide for treatment of status epilepticus

Acta Neurologica Scandinavica

Volumn 123, Issue 2, 2011, Pages 137-141

  Kellinghaus, C ^a   Berning, S ^a   Immisch, I ^b   Larch, J ^c,d   Rosenow, F ^b   Rossetti, A O ^e   Tilz, C ^f   Trinka, E ^c,d  

^a Andreas Bannowsky Ltd   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d Salzburger Landeskliniken ^*  (Austria)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

Efficacy; Intravenous; Outcome; Status epilepticus; Tolerability

Indexed keywords

ALUMINUM; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CLONAZEPAM; DOMPERIDONE; ETIRACETAM; HARKOSERIDE; LAMOTRIGINE; PHENYTOIN; PREGABALIN; PROPOFOL; VALPROIC ACID;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; AUSTRIA; BOLUS INJECTION; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; GERMANY; GRAND MAL SEIZURE; HUMAN; HYPOTENSION; MALE; RETROSPECTIVE STUDY; SIMPLE PARTIAL SEIZURE; SWITZERLAND; TREATMENT OUTCOME;

ACETAMIDES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; STATUS EPILEPTICUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650789188     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01423.x     Document Type: Article

References (12)

1. Meierkord H, Boon P, Engelsen B et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2009;17:348-55.
2. Knake S, Hamer HM, Rosenow F. Status epilepticus: a critical review. Epilepsy Behav 2009;15:10-4.
3. Krauss G, Ben Menachem E, Mameniskiene R et al. Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures. Epilepsia 2010;51:951-7.
4. Kellinghaus C, Berning S, Besselmann M. Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 2009;14:429-31.
5. Tilz C, Resch R, Hofer T, Eggers C. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 2009;51:316-7.
6. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205-10.
7. Treiman DM, Meyers PD, Walton NY et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-8.
8. Berning S, Boesebeck F, Van Baalen A, Kellinghaus C. Intravenous levetiracetam as treatment for status epilepticus. J Neurol 2009;256:1634-42.
9. Gámez-Leyva G, Aristín JL, Fernández E, Pascual J. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series. CNS Drugs 2009;23:983-7.
10. Möddel G, Bunten S, Dobis C et al. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry 2009;80:689-92.
11. Tripathi M, Vibha D, Choudhary N et al. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure 2010;19:109-11.
12. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005;64:353-5.